Slebir John L bought SPRY
November 2, 2026 · Form 4 insider transaction
Slebir John L bought 1,199,482 shares of ARS Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,199,482
Price
$0.00
Total value
N/A
InsiderSlebir John L
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateNovember 2, 2026
Filing dateNovember 4, 2026
Shares owned after1,199,482
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to the option vest on October 26, 2027, and the remaining shares will vest monthly thereafter over three years.